Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $245.64.
A number of equities research analysts have recently commented on AXON shares. JMP Securities reiterated a “market outperform” rating and set a $235.00 target price on shares of Axon Enterprise in a research note on Friday, September 29th. Raymond James raised their target price on Axon Enterprise from $223.00 to $233.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 8th. TheStreet raised Axon Enterprise from a “c” rating to a “b” rating in a report on Tuesday, November 7th. Finally, StockNews.com assumed coverage on shares of Axon Enterprise in a report on Thursday, October 5th. They set a “hold” rating on the stock.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Up 1.6 %
Shares of NASDAQ:AXON opened at $256.84 on Friday. The stock has a market cap of $19.25 billion, a price-to-earnings ratio of 131.71 and a beta of 0.88. The business’s 50 day moving average is $225.85 and its 200 day moving average is $207.38. Axon Enterprise has a 12-month low of $162.39 and a 12-month high of $260.35. The company has a quick ratio of 2.78, a current ratio of 3.15 and a debt-to-equity ratio of 0.44.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings data on Tuesday, November 7th. The biotechnology company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.40 by $0.31. The firm had revenue of $413.60 million during the quarter, compared to analyst estimates of $393.77 million. Axon Enterprise had a net margin of 9.96% and a return on equity of 12.63%. On average, sell-side analysts forecast that Axon Enterprise will post 2.29 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Axon Enterprise news, President Joshua Isner sold 1,956 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $253.46, for a total value of $495,767.76. Following the completion of the transaction, the president now directly owns 347,526 shares of the company’s stock, valued at approximately $88,083,939.96. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 635 shares of Axon Enterprise stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $230.38, for a total transaction of $146,291.30. Following the completion of the sale, the insider now directly owns 236,020 shares in the company, valued at $54,374,287.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Joshua Isner sold 1,956 shares of the stock in a transaction on Monday, December 18th. The stock was sold at an average price of $253.46, for a total transaction of $495,767.76. Following the completion of the transaction, the president now directly owns 347,526 shares in the company, valued at approximately $88,083,939.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 79,642 shares of company stock valued at $16,887,255. Company insiders own 6.10% of the company’s stock.
Hedge Funds Weigh In On Axon Enterprise
Several institutional investors have recently modified their holdings of the company. ICA Group Wealth Management LLC bought a new position in Axon Enterprise during the fourth quarter valued at approximately $25,000. Hollencrest Capital Management purchased a new position in Axon Enterprise in the 1st quarter worth $29,000. Jones Financial Companies Lllp bought a new stake in Axon Enterprise in the second quarter worth $30,000. Spire Wealth Management purchased a new stake in Axon Enterprise during the first quarter valued at about $31,000. Finally, First Capital Advisors Group LLC. bought a new position in shares of Axon Enterprise during the second quarter valued at about $33,000. 76.52% of the stock is currently owned by institutional investors.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
NASDAQ: AXON” width=”600″ height=”385″ loading=”lazy”>
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
